Roberto Cuca - 20 Feb 2026 Form 4 Insider Report for TELA Bio, Inc. (TELA)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
24 Feb 2026, 20:00:16 UTC
Prior SEC filing
25 Feb 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Megan Smeykal, Attorney-in-Fact

Key filing fact

Roberto Cuca filed Form 4 for TELA Bio, Inc. (TELA) on 24 Feb 2026.

Key facts

  • This page summarizes Roberto Cuca's Form 4 filing for TELA Bio, Inc. (TELA).
  • 4 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 24 Feb 2026, 20:00.

Change

  • Previous filing in this sequence was filed on 25 Feb 2025.
  • Current net transaction value: -$7,438.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001591474 Primary reporting owner

Cuca Roberto

Relationship
COO and CFO
Address
C/O TELA BIO, INC., 1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN
Signature
/s/ Megan Smeykal, Attorney-in-Fact
Signature date
24 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TELA transaction

Common Stock

Award

Transaction value
$0
Shares
+57,000
Change %
+27%
Price
$0.000000
Shares after
267,391
Date
20 Feb 2026
Ownership
Direct
Footnotes
F1, F2
TELA transaction

Common Stock

Tax liability

Transaction value
$3,429
Shares
-4,780
Change %
-1.8%
Price
$0.7174
Shares after
262,611
Date
21 Feb 2026
Ownership
Direct
Footnotes
F3
TELA transaction

Common Stock

Tax liability

Transaction value
$4,009
Shares
-5,234
Change %
-2%
Price
$0.7660
Shares after
257,377
Date
23 Feb 2026
Ownership
Direct
Footnotes
F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TELA transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+85,000
Change %
Price
$0.000000
Shares after
85,000
Date
20 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
85,000
Exercise price
$0.7170
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

These restricted stock units ("RSUs") will vest in four equal annual installments beginning on February 20, 2027, subject to the Reporting Person's continuous service through the applicable vesting dates.

Footnote F2

Includes 1,079 shares acquired under the Company's employee stock purchase plan on each of July 31, 2025 and January 30, 2026.

Footnote F3

Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs.

Footnote F4

The option vests 25% on February 20, 2027, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .